You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

AZELASTINE HYDROCHLORIDE ALLERGY Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Azelastine Hydrochloride Allergy patents expire, and when can generic versions of Azelastine Hydrochloride Allergy launch?

Azelastine Hydrochloride Allergy is a drug marketed by Apotex and is included in one NDA.

The generic ingredient in AZELASTINE HYDROCHLORIDE ALLERGY is azelastine hydrochloride. There are twelve drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the azelastine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Azelastine Hydrochloride Allergy

A generic version of AZELASTINE HYDROCHLORIDE ALLERGY was approved as azelastine hydrochloride by APOTEX INC on April 30th, 2009.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AZELASTINE HYDROCHLORIDE ALLERGY?
  • What are the global sales for AZELASTINE HYDROCHLORIDE ALLERGY?
  • What is Average Wholesale Price for AZELASTINE HYDROCHLORIDE ALLERGY?
Summary for AZELASTINE HYDROCHLORIDE ALLERGY
Drug patent expirations by year for AZELASTINE HYDROCHLORIDE ALLERGY
Recent Clinical Trials for AZELASTINE HYDROCHLORIDE ALLERGY

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
MEDA Pharma GmbH & Co. KGPhase 2
SandozPhase 1
Nanjing University of Chinese MedicineN/A

See all AZELASTINE HYDROCHLORIDE ALLERGY clinical trials

Pharmacology for AZELASTINE HYDROCHLORIDE ALLERGY

US Patents and Regulatory Information for AZELASTINE HYDROCHLORIDE ALLERGY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex AZELASTINE HYDROCHLORIDE ALLERGY azelastine hydrochloride SPRAY, METERED;NASAL 216421-001 May 29, 2024 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.